Regular exercise, plasminogen activator inhibitor-1 (PAI-I) activity and the 4G/5G promoter polymorphism in the PAI-1 gene

被引:0
|
作者
Väisänen, SB
Humphries, SE
Luong, LA
Penttilä, I
Bouchard, C
Rauramaa, R
机构
[1] Univ Kuopio, Kuopio Res Inst Exercise Med, FIN-70100 Kuopio, Finland
[2] Univ Kuopio, Dept Physiol, FIN-70100 Kuopio, Finland
[3] UCLMS, Rayne Inst, Dept Med, Ctr Cardiovasc Genet, London, England
[4] Kuopio Univ Hosp, Dept Clin Chem, SF-70210 Kuopio, Finland
[5] Univ Laval, Phys Act Sci Lab, St Foy, PQ G1K 7P4, Canada
[6] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland
关键词
plasminogen activator inhibitor-1; DNA polymorphism; exercise training; randomised clinical trial; population based study;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this controlled randomised clinical trial was to investigate the effects of regular low to moderate intensity physical activity on plasminogen activator inhibitor-1 (PAI-1) activity during three years while taking into account the 4G/5G polymorphism in the promoter of the PAI-1 gene. Male subjects (age 52-62 years, n = 132) were randomised into an exercise or a (non-intervention) reference group. Aerobic threshold increased by 8.8% (p = 0.025) in the exercise group, and decreased by 1.1% in the non-intervention group, while PAI-1 activity did not change significantly in either study group. However! homo zygotes for the 4G allele in the exercise group showed a 36% reduction in PAI-1 (p = 0.025). In conclusion, although regular moderate physical activity did not decrease PAI-1 activity in the whole group, regular exercise ma) be effective for controlling elevated PAI-1 level in subjects homozygous for the 4G allele.
引用
收藏
页码:1117 / 1120
页数:4
相关论文
共 50 条
  • [21] The 4G/5G polymorphism of the plasminogen activator inhibitor 1 (PAI-1) gene and thrombosis in patients with antiphospholipid syndrome
    Mukhametova, L., I
    Gulin, D. A.
    Aisina, R. B.
    Reshetnyak, T. M.
    Ostryakova, E., V
    Seredavkina, N., V
    Patrusheva, N. L.
    Patrushev, L., I
    Aleksandrova, E. N.
    Gershkovich, K. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 418 - 419
  • [22] Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population
    Dina M. R. Shammaa
    Amira S. Sabbagh
    Ali T. Taher
    Ghazi S. Zaatari
    Rami A. R. Mahfouz
    Molecular Biology Reports, 2008, 35 : 453 - 457
  • [23] ELEVATED LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1), 4G/5G PROMOTER POLYMORPHISM AND THE DEVELOPMENT OF ATHEROTHROMBOTIC AND HEMORRHAGIC STROKE
    CATTO, AJ
    CARTER, AM
    STICKLAND, MH
    BAMFORD, J
    DAVIES, JA
    GRANT, PJ
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1399 - 1399
  • [24] Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
    Nader Nemr
    Mohamed Mandour
    Dahlia Badran
    Rania Kishk
    Fawzy Attia
    Abdullah Hashish
    Ahmed Gaber
    Bulletin of the National Research Centre, 43 (1)
  • [25] The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
    Yildirim, Malik Ejder
    Karakus, Savas
    Kurtulgan, Hande Kucuk
    Kilicgun, Hasan
    Ersan, Serpil
    Bakir, Sevtap
    BIOCHEMICAL GENETICS, 2017, 55 (04) : 314 - 321
  • [26] The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
    Malik Ejder Yıldırım
    Savas Karakuş
    Hande Küçük Kurtulgan
    Hasan Kılıçgün
    Serpil Erşan
    Sevtap Bakır
    Biochemical Genetics, 2017, 55 : 314 - 321
  • [27] THE 4G/5G GENETIC-POLYMORPHISM IN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE IS ASSOCIATED WITH DIFFERENCES IN PLASMA PAI-1 ACTIVITY BUT NOT WITH RISK OF MYOCARDIAL-INFARCTION IN THE ECTIM STUDY
    YE, S
    GREEN, FR
    SCARABIN, PY
    NICAUD, V
    BARA, L
    DAWSON, SJ
    HUMPHRIES, SE
    EVANS, A
    LUC, G
    CAMBOU, JP
    ARVEILER, D
    HENNEY, AM
    CAMBIEN, F
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (03) : 837 - 841
  • [28] LACK OF ASSOCIATION BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 4G/5G GENE PROMOTER POLYMORPHISM AND PAI-1 PLASMA LEVELS IN PATIENTS WITH ISCHEMIC STROKE
    Gadelha, T.
    Sabino, A. Paula
    Ribeiro, D. Dias
    Domingueti, C. Pereira
    dos Santos, M. Silva
    Gadelha, T.
    Carvalho, M. G.
    Fernandes, A. P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 290 - 290
  • [29] Plasminogen Activator Inhibitor-1 (PAI-1) Gene 4G/5G Promoter Polymorphism is Seen in Higher Frequency in the Indian Patients With Deep Vein Thrombosis
    Akhter, Mohammed Suhail
    Biswas, Arijit
    Ranjan, Ravi
    Meena, Arvind
    Yadav, Birendra Kumar
    Sharma, Amit
    Saxena, Renu
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (02) : 184 - 188
  • [30] The hypofibrinolytic 4G/4G polymorphism of the plasminogen activator inhibitor-1 (PAI-1) gene in women with obstetric complications.
    Glueck, CJ
    Kupferminc, MJ
    Fontaine, RN
    Wang, P
    Weksler, BB
    Eldor, A
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) : 261A - 261A